Susan Lark, MD Speaks Out Against the Newest Osteoporosis Dru...( Susan Lark M...),Health

Susan Lark, MD, noted medical researcher and women's health practitioner, has spoken out against the newest prescription osteoporosis medication on the market, Reclast, as well as other oral bisphosphonates such as Boniva, Actonel, and Fosamax.

Potomac, MD (PRWEB) November 28, 2008 -- Susan Lark, MD, noted medical researcher and women's health practitioner, has spoken out against the newest prescription osteoporosis medication on the market, Reclast, as well as other oral bisphosphonates such as Boniva, Actonel, and Fosamax.

"Without a doubt, the newest osteoporosis drug on the market, Reclast, is not the miracle drug its marketers want you to believe it is. While this once-yearly IV treatment is touted as safe and convenient, its side effects far outweigh its benefits," says Dr. Lark. "In fact, all bisphosphonates should be avoided because they can cause gastrointestinal side effects, chemical burning of the esophagus, infection and death of bone tissue in the jaw (called osteonecrosis), and kidney toxicity. And Reclast, in particular, has been shown to cause heart rhythm abnormalities like atrial fibrillation. These side effects are dangerous and hardly seem worth it, especially when there are extremely safe, natural ways to prevent and treat bone loss."

In addition, according to Dr. Lark, bisphosphonates don't actually stimulate new bone growth. Instead, they slow the rate of loss of old bone by blocking the action of osteoclasts--cells that are meant to dismantle old, damaged bone tissue so it can be replaced by new tissue, made by osteoblasts. This means the bones in a woman taking a bisphosphonate are increasingly constructed of over-aged, damaged bone cells that have been encouraged to linger lon
'/>"/>